MedPath

Omega-3 in the treatment of Attention Deficit Hyperactivity Disoder

Not Applicable
Conditions
attention deficit hyperactivity disorder.
Disturbance of activity and attention
Registration Number
IRCT138803122000N1
Lead Sponsor
Behavioral Sciences Research Center, Shahid Beheshti University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
40
Inclusion Criteria

1- children with 6-12 years of age, 2- ADHD diagnosis based on DSM-IV-TR, 3- Score of at least 20 in ADHD-RS (parent form). Exclusion criteria:
1- Any major comorbid psychiatric disorder except ODD and LD based on K-SADS, 2- IQ below 70, 3- Use of any psychotropic drug or substance in at least 2 weeks before the study, 4- any major neurological disease, 5- use of PUFA included substances or nutrients more than once a week

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath